Malignant neoplasm of prostate
|
0.330 |
Biomarker
|
disease |
BEFREE |
Podocalyxin (Podxl) is a CD34 orthologue and cell surface sialomucin reported to have roles in renal podocyte diaphragm slit development; vascular cell integrity; and the progression of blood, breast, and prostate cancers.
|
28408238 |
2017 |
Malignant neoplasm of prostate
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of podocalyxin in prostate cancer renders the protein a putative immunohistochemical marker of prostate cancer that may contribute to stratification of patients for optimal treatment.
|
30396958 |
2018 |
Malignant neoplasm of prostate
|
0.330 |
Biomarker
|
disease |
CTD_human |
These results implicate PODXL as a candidate prostate cancer tumor aggressiveness gene mapping to chromosome 7q32-q33.
|
16434482 |
2006 |
Malignant neoplasm of prostate
|
0.330 |
Biomarker
|
disease |
BEFREE |
These results implicate PODXL as a candidate prostate cancer tumor aggressiveness gene mapping to chromosome 7q32-q33.
|
16434482 |
2006 |
Nephrosis, congenital
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis.
|
24048372 |
2014 |
Nephrosis, congenital
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
|
28117080 |
2017 |
Nephrosis, congenital
|
0.310 |
Biomarker
|
disease |
BEFREE |
Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome.
|
29244787 |
2017 |
Carotid Atherosclerosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes.
|
22016802 |
2011 |
Arterial Diseases, Common Carotid
|
0.300 |
Biomarker
|
disease |
CTD_human |
Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes.
|
22016802 |
2011 |
Atypical juvenile parkinsonism
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism.
|
26864383 |
2016 |
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism.
|
26864383 |
2016 |
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE
|
0.110 |
GeneticVariation
|
disease |
CLINVAR |
Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism.
|
26864383 |
2016 |
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysautonomia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dyskinetic syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hallucinations
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Restless Legs Syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Talipes cavus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Akinesia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Panic Attacks
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Social Communication Disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gastroparesis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anarthria speech disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|